News for Schrödinger, Inc. (SDGR)

[url="]Schrödinger[/url], Inc. (Nasdaq: SDGR) today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025. Thi

Schrödinger (Nasdaq: SDGR) today announced that management will participate in the following conferences in March: TD Cowen 45th Annual Health Care Conferen

Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future prospects. Read more on SDGR stock here.

Schrödinger (Nasdaq: SDGR) will report its fourth quarter and full-year 2024 financial results on Wednesday, February 26, 2025, after the financial markets cl

PR NewswireSHANGHAI, Jan. 27, 2025 SHANGHAI, Jan. 27, 2025 /PRNewswire/ -- On January 27th, 2025, Beijing Time, Qiming Venture Partners' portfolio company

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street's Radar. In this article, we are going to take a look at where Schrödinger, Inc.

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where Schrödinger, Inc.

Schrodinger stock soars; Hunterbrook positive as AI integration promises drug discovery advances

U.S. stocks were higher, with the Dow Jones index gaining over 100 points on Wednesday. Shares of Seagate Technology Holdings plc STX rose sharply during Wedne...

[url="]Schrödinger[/url], Inc. (Nasdaq: SDGR) today provided an update on its progress across the business in 2024 and announced its strategic priorities for

Schrödinger's growth was soft in Q3, and the company's losses continue to grow due to investments in internal programs. Check out my analysis of SDGR stock.

Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference. T

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on November 14, 2024, the company granted restricted stock units (RSUs) with respect to 2,785 shares of t

[url=

SHANGHAI, Oct. 26, 2024 /PRNewswire/ -- On October 25th, 2024, Beijing Time, WeRide, a world-leading autonomous driving company and Qiming Venture Partners' portfolio company, began trading on Nasdaq. This marks a historic milestone as both the world's first pure-play autonomous driving company to go public and the first publicly listed Robotaxi company. WeRide (NASDAQ:WRD) offered at $15.5/ADS, representing a market cap of $4.3 billion.

Schrödinger has suffered setbacks over the past year, but near 52-week lows, the stock presents substantial value. Read more on SDGR stock here.

Pennsylvania-based healthcare business Societal CDMO, Inc. (SCTL) is up over 132% in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Tango Therapeutics has 2 PRMT5 inhibitors in clinical development. Its shares spiked after positive data from PRMT5 inhibitor. Find out why TNGX stock is a Buy.

UBTech is the first humanoid robot company to go public on HKExQiming is UBTech's early institutional investor, exclusively investing in its Series A round in 2015UBTech's listing is Qiming's eighth...